Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hecht Olsen

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|August 29, 2003
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE studyLars H Lindholm, Björn Dahlöf, Jonathan M Edelman, et al.
The American Journal of Medicine|January 20, 2019
Pulse Pressure, Cardiovascular Events, and Intensive Blood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT)Manan Pareek, Muthiah Vaduganathan, Tor Biering-Sørensen, et al.
JAMA|February 15, 2022
Validation Status of Blood Pressure Measuring Devices Sold GloballyDean S Picone, Norm R C Campbell, Aletta E Schutte, et al.
Journal of Human Hypertension|August 8, 2025
Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional studySon Bao Nguyen, Thomas Bastholm Olesen, Sidsel Louise Domazet, et al.
Blood Pressure|July 2, 2019
Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE studyAnne C K Larstorp, Ildri M Stokke, Sverre E Kjeldsen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 9, 2006
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudyEigil Fossum, Michael Hecht Olsen, Aud Høieggen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2021
Building research capacity within cardiovascular disease prevention and management in low- and middle-income countries: A collaboration of the US Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension LeagueDinesh Neupane, Laura K Cobb, Bethany Hall, et al.
Journal of Hypertension|March 6, 2020
ReplyJames E Sharman, Eoin O'Brien, Bruce Alpert, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 4, 2026
Validating National Registry Data for Randomised Trials: Comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trialTherese Lucia Friis Holmager, Anna Meta Dyrvig Kristensen, Morten Wang Fagerland, et al.
Journal of Hypertension|October 5, 2023
Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysisAnupa Rijal, Tara Ballav Adhikari, Sarmila Dhakal, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|August 29, 2003
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE studyLars H Lindholm, Björn Dahlöf, Jonathan M Edelman, et al.
The American Journal of Medicine|January 20, 2019
Pulse Pressure, Cardiovascular Events, and Intensive Blood-Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT)Manan Pareek, Muthiah Vaduganathan, Tor Biering-Sørensen, et al.
JAMA|February 15, 2022
Validation Status of Blood Pressure Measuring Devices Sold GloballyDean S Picone, Norm R C Campbell, Aletta E Schutte, et al.
Journal of Human Hypertension|August 8, 2025
Impact of moderate to vigorous physical activity on systemic vascular resistance in Danish adults with recently diagnosed type 2 diabetes: a cross-sectional studySon Bao Nguyen, Thomas Bastholm Olesen, Sidsel Louise Domazet, et al.
Blood Pressure|July 2, 2019
Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE studyAnne C K Larstorp, Ildri M Stokke, Sverre E Kjeldsen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 9, 2006
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudyEigil Fossum, Michael Hecht Olsen, Aud Høieggen, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 1, 2021
Building research capacity within cardiovascular disease prevention and management in low- and middle-income countries: A collaboration of the US Centers for Disease Control and Prevention, the Lancet Commission on Hypertension Group, Resolve to Save Lives, and the World Hypertension LeagueDinesh Neupane, Laura K Cobb, Bethany Hall, et al.
Journal of Hypertension|March 6, 2020
ReplyJames E Sharman, Eoin O'Brien, Bruce Alpert, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 4, 2026
Validating National Registry Data for Randomised Trials: Comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trialTherese Lucia Friis Holmager, Anna Meta Dyrvig Kristensen, Morten Wang Fagerland, et al.
Journal of Hypertension|October 5, 2023
Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysisAnupa Rijal, Tara Ballav Adhikari, Sarmila Dhakal, et al.
Pageof 13